Results 201 to 210 of about 180,645 (290)
We evaluated the usefulness of remote monitoring for advanced heart failure patients using left‐ventricular assist devices (LVADs) in France. A national, retrospective study on a web application (Satelia) at nine locations was conducted. Specialized remote monitoring could facilitate LVAD follow‐ups and improve outcomes.
Clément Delmas +12 more
wiley +1 more source
Diagnostic value of OSA-18 scale combined with the lowest blood oxygen saturation at night in children with obstructive sleep apnea. [PDF]
Su P, Yuan Y, Liao H, Fan Y, Ai T.
europepmc +1 more source
14 100 LVAD patients across 21 studies were analyzed. Findings indicated that obese LVAD recipients had lower short‐term mortality and higher risk of infection, thrombosis and right heart failure. There was no difference in long‐term survival between obese and non‐obese patients.
Hugh Jacobs +11 more
wiley +1 more source
Elevated monocyte-to-HDL cholesterol ratio predicts severity of obstructive sleep apnea syndrome. [PDF]
Ahmed AM +4 more
europepmc +1 more source
Pediatric obstructive sleep apnea
Bhatt, Ayushi +2 more
openaire +2 more sources
ABSTRACT Aim Children with Prader‐Willi syndrome (PWS) are at increased risk of both central (CSA) and obstructive sleep apnoea (OSA). Studies examining the effects of growth hormone have focused on older children; however, therapy is often initiated before the age of 2 years.
Michelle Ip +7 more
wiley +1 more source
Rating Scales for Obstructive Sleep Apnea Syndrome: The Importance of a Comprehensive Assessment. [PDF]
Bordoni B, Morabito B.
europepmc +1 more source
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody +5 more
wiley +1 more source
Real‐world patients with severe eosinophilic asthma treated with benralizumab showed early and sustained improvements in symptoms. Clinically meaningful improvements began as early as one week after benralizumab initiation, regardless of previous biologic use, and further improved over the following year.
Erika Penz +12 more
wiley +1 more source
Obstructive sleep apnea and outcomes in acute pulmonary embolism: A large-scale database study. [PDF]
Alawad S +4 more
europepmc +1 more source

